WeVote
Log In

Bill

Bill

S 4495

Requires health benefits coverage for treatment of lipedema.

2024-2025 Regular Session Introduced by Teresa Ruiz and 1 co-sponsor

New Jersey bill mandates insurance coverage for lipedema treatments, reclassifying the condition from cosmetic to medical and expanding patient access to care.

Introduced in the Senate, Referred to Senate Commerce Committee
#healthinsur
0
WeVote Research Nonpartisan
Bill Summary · S 4495

Legislative bill overview

S 4495 requires health insurance plans in New Jersey to cover medical and surgical treatments for lipedema, a chronic condition characterized by abnormal fat accumulation in the legs and sometimes arms. The bill mandates that insurers treat lipedema as a medical condition eligible for coverage rather than as a cosmetic concern.

Why is this important

Lipedema affects millions of people, predominantly women, and can cause pain, mobility issues, and psychological distress, yet many insurance plans deny coverage claiming it is cosmetic. Mandating coverage would make treatments—including compression therapy, lymphatic drainage, and surgical options—financially accessible to patients who currently face significant out-of-pocket costs or go untreated.

Potential points of contention

  • Insurance cost impacts: Insurers may argue that expanded coverage obligations increase premiums for all policyholders, though actual cost impact depends on lipedema prevalence and treatment utilization rates
  • Definition and diagnosis challenges: Medical consensus on lipedema diagnostic criteria varies, raising questions about which patients qualify and potential for over-treatment or misdiagnosis
  • Surgical coverage scope: The bill's inclusion of surgical treatments could be contentious, as surgical efficacy for lipedema remains debated in the medical community and costs can be substantial

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.